Never miss a story

Get subscribed to our newsletter


×
Prokerala/wikipedia

90% of those who received the booster dose exhibited a "detectable neutralising antibody response.

Six months following the second Covid treatment, 90% of those who received the booster dose exhibited a "detectable neutralising antibody response" against the wild-type strain, according to Bharat Biotech.

"Cell-mediated immunity and neutralising antibodies to both homologous (D614G) and heterologous (Alpha, Beta, Delta, and Delta plus) strains persisted above baseline six months after a two-dose BBV152 vaccination series, though the magnitude of the responses had declined," the vaccine manufacturer said in a statement.

Keep Reading Show less

Popular